Vertex Pharmaceuticals Incorporated (VX1.DE) XETRA

385.90

-8.15(-2.07%)

Updated at January 14 04:57PM

Currency In EUR

Valuation

Market Cap103.56B
Enterprise Value100.74B
P/E Ratio31.35
PEG Ratio23.33
Price/Sales Ratio9.87
Price/Book Ratio6.65
Enterprise/Revenue9.6
Enterprise/EBITDA24.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.31
Operating Margin0.34

Management Effectiveness

Return On Assets0.15
Return On Equity0.22

Income Statement

Revenue11.02B
Revenue/Share45.87
Gross Profit9.49B
EBITDA486.3M
Net Income-535.6M
Diluted EPS-2.05

Balance Sheet

Total Cash6.29B
Total Cash/Share24.6
Total Debt1.83B
Total Debt/Equity0.11
Current Ratio2.36
Book Value Per Share67.76

Price History

52-Week Change-3.39
52-Week High478.1
52-Week Low312.65
Moving Average 50 Days382.19
Moving Average 200 Days377.3

Statistics

Average Volume103
Shares Outstanding256.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A